CD22
Protein found in humans
CD22 (Cluster of Differentiation 22) is a protein that in humans is encoded by the CD22 gene. It is a member of the SIGLEC family of lectins and is primarily expressed on the surface of B cells. CD22 plays a crucial role in the regulation of the immune response.
Structure
CD22 is a type I transmembrane protein composed of an extracellular domain, a transmembrane domain, and a cytoplasmic tail. The extracellular domain contains multiple immunoglobulin-like domains, which are involved in binding to sialic acid-containing ligands. The cytoplasmic tail contains several tyrosine residues that become phosphorylated upon activation, serving as docking sites for SH2 domain-containing signaling molecules.
Function
CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. Upon BCR engagement, CD22 becomes phosphorylated and recruits SHP-1, a tyrosine phosphatase, which dephosphorylates key signaling molecules, thereby dampening the BCR signal. This negative regulation is essential for maintaining B cell tolerance and preventing autoimmunity.
Expression
CD22 is expressed on the surface of mature B cells and is absent on plasma cells. It is also found in the cytoplasm of pro-B cells and pre-B cells but is not expressed on hematopoietic stem cells or other lymphoid or myeloid cells.
Clinical significance
CD22 is a target for therapeutic intervention in B cell-related diseases, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. Monoclonal antibodies and antibody-drug conjugates targeting CD22 have been developed and are used in the treatment of these malignancies.
Research
Research on CD22 continues to explore its role in B cell biology and its potential as a therapeutic target. Studies are also investigating the mechanisms by which CD22 regulates immune responses and its involvement in autoimmune diseases.
See also
References
CD22
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD